Ms Myriam MendilaChief Scientific Officer at CureVacSpeaker
Agenda Sessions
Development of an mRNA Based Off-The-Shelf Cancer Vaccine for Treatment Of Glioblastoma
, 14:45View SessionFuture of RNA Therapeutics
, 16:10View Session